FDA approves new drug for advanced breast cancer treatment

FDA approves new drug for advanced breast cancer treatment

The Food and Drug Administration on Friday approved a new, targeted breast cancer drug for patients who become resistant to hormone therapy.

FDA Grants Accelerated Approval to a New Breast Cancer Treatment

The U.S. Food and Drug Administration expanded treatment options for adult patients with advanced breast cancer, reflecting the FDA’s commitment to advancing medical innovation and getting new treatments to patients who need them. Image for illustration purposes